Product information and disease description
Product description
28 evidence topics · 18 sources
QTORIN rapamycin 3.9 percent gel
Microcystic lymphatic malformations
- Manufacturer
- Palvella Therapeutics
- Regulatory submission
- NDA submitted August 2026
- Last updated